ArticleFrontiers in microbiology2022

A Novel Toll-Like Receptor 2 Agonist Protects Mice in a Prophylactic Treatment Model Against Challenge With

Chih-Yuan Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.